MYSM1 Antibody

(Synonyms: Myb-like; SWIRM and MPN domains 1; 2ADUB; 2A-DUB; RP4-592A1.1)

MYSM1 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to MYSM1.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, IHC-P

  • Reactivity :

    Human, Mouse

  • Formulation:

    Supplied in PBS (pH 7.4), 0.05% NaN3, 40% Glycerol.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
Dilution Ratio 1:500-1:2000 1:50-1:100

Product Details

Description

MYSM1 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to MYSM1.

  • Host Rabbit
  • Clonality Polyclonal
  • Species Reactivity
    Human, Mouse
  • Observed Molecular Weight
    Observed band size: 95 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 95 kDa
Species Reactivity Database
Immunogen

Synthetic peptide corresponding to Human MYSM1.The exact sequence is proprietary to MCE.

Sensitivity

Endogenous

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in PBS (pH 7.4), 0.05% NaN3, 40% Glycerol.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    Metalloprotease with deubiquitinase activity that plays important regulator roles in hematopoietic stem cell function, blood cell production and immune response (PubMed:24062447, PubMed:26220525, PubMed:28115216). Participates in the normal programming of B-cell responses to antigen after the maturation process (By similarity). Within the cytoplasm, plays critical roles in the repression of innate immunity and autoimmunity (PubMed:33086059). Removes 'Lys-63'-linked polyubiquitins from TRAF3 and TRAF6 complexes (By similarity). Attenuates NOD2-mediated inflammation and tissue injury by promoting 'Lys-63'-linked deubiquitination of RIPK2 component (By similarity). Suppresses the CGAS-STING1 signaling pathway by cleaving STING1 'Lys-63'-linked ubiquitin chains (PubMed:33086059). In the nucleus, acts as a hematopoietic transcription regulator derepressing a range of genes essential for normal stem cell differentiation including EBF1 and PAX5 in B-cells, ID2 in NK-cell progenitor or FLT3 in dendritic cell precursors (PubMed:24062447). Deubiquitinates monoubiquitinated histone H2A, a specific tag for epigenetic transcriptional repression, leading to dissociation of histone H1 from the nucleosome (PubMed:17707232)

  • Subcellular Localization

    Nucleus; Cytoplasm

  • Expression


    Induction:By DNA from viral infection and intracellular DNA

  • Isoforms & Post-Translational Modification

    Q5VVJ2 has 3 isomers: Q5VVJ2-1: 95032 Da (predicted); Q5VVJ2-2: 66421 Da (predicted); Q5VVJ2-3: 26716 Da (predicted).

  • Subunit

    Component of a large chromatin remodeling complex, at least composed of MYSM1, PCAF, RBM10 and KIF11/TRIP5. Binds histones (PubMed:17707232). Interacts with NFIL3; this interaction is critical for their correct recruitment to the ID2 locus during natural killer cell maturation (PubMed:24062447)

  • SwissProt ID

    Q5VVJ2

  • Gene ID
  • Synonyms

    Myb-like; SWIRM and MPN domains 1; 2ADUB; 2A-DUB; RP4-592A1.1

MYSM1 Antibody Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00